U.S. drugmaker Eli Lilly & Co (NYSE:LLY - News) is in talks to form a partnership with, and potentially invest in, Turkish generic-drug company Mustafa Nevzat Ilac Sanayii AS (MN Pharmaceuticals), the Wall Street Journal reported, citing people familiar with the matter. The talks, which are in an early stage, marks the latest effort by a big Western multinational to tap emerging markets for growth. The discussions with Indianapolis-based Lilly are currently focused only on a minority interest, the newspaper reported.
